Postexposure prophylaxis for HIV in children and adolescents after sexual assault: A prospective observational study in an urban medical center

Sexually Transmitted Diseases

Volumn 34, Issue 2, 2007, Pages 65-68

  Neu, Natalie ^a   Heffernan Vacca, Susan ^b   Millery, Mari ^c   Stimell, Mindy ^a   Brown, Jocelyn ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANUS; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG INDUCED HEADACHE; EMERGENCY WARD; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CENTER; HEALTH PROGRAM; HEART RATE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PEDIATRICS; PROSPECTIVE STUDY; SCHOOL CHILD; SEXUAL CRIME; SIDE EFFECT; URBAN AREA; VAGINA;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; DRUG COMBINATIONS; FEMALE; HIV; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX OFFENSES; ZIDOVUDINE;

EID: 33846404117     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000225329.07765.d8     Document Type: Article

References (21)

1. Peddle N, Wang C. Current Trends in Child Abuse Prevention, Reporting and Fatalities: The 1999 Fifty State Survey. Chicago: National Center on Child Abuse Prevention Research, 2001.
2. Fleming D, Wasserheit J. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
3. DeGruttola V, Seage G, Mayer K, et al. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989; 42:849-856.
4. Downs A, De Vincenzi I, for the European Study Group in Heterosexual Transmission of HIV. Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual contacts. J Acquir Immun Defic Syndr Hum Retrovirol 1996; 11:388-395.
5. Connors E, Sperling R, Gelber R, et al. Reduction of maternal infant transmission of HIV type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
6. Guay L, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 transmission of HIV-1 in Kampala, Uganda: HIVNET 012 Randomised Trial. Lancet 1999; 354:795-802.
7. Shih C, Kaneshima H, Rabin L, et al. Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991; 163:625-627.
8. Centers for Disease Control, Prevention. Updated US Public Health Service guidelines for the management of occupational exposure to HBV, HCV and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001; 50:1-54.
9. Medical Care Criteria Committee. HIV Post exposure prophylaxis for children beyond the perinatal period. Albany, NY: New York Department of Health AIDS Institute, March 2002, Chapter 19:1-26. Available at: http://www. hivguidelines.org.
10. Babl F, Cooper E, Damon B, et al. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med 2000; 18:282-287.
11. Merchant R, Becker B, Mayer K, et al. Emergency department blood or body fluid exposure evaluation and HIV postexposure prophylaxis usage. Acad Emerg Med 2003; 10:1345-1353.
12. Merchant R, Keshavarz R, Low C. HIV post-exposure prophylaxis provided at an urban paediatric emergency department to female adolescents after sexual assault. Emerg Med J 2004; 21:449-451.
13. Merchant R, Keshavarz R. Human immunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 2001; 108: e38.
14. Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use or other nonocupational exposures to HIV in the United States: Recommendations from the US Department of Health and Human Services. MMWR Morb Mortal Wkly Rep 2005; 54:1020.
15. Bassett I, Freedberg K, Walensky R. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis 2004; 39:395-401.
16. Parkin J, Anderson M, El-Gadi S, Forster G, Pinching A. Tolerability and side-effects of post-exposure prophylaxis for HIV infection. Lancet 2000; 355:722-723.
17. Limb S, Kawar M, Forster G. HIV post-exposure prophylaxis after sexual assault: The experience of a sexual assault service in London. Int J STD AIDS 2002; 13:602-605.
18. Wiebe E, Comay S, McGregor M, Ducceschi S. Offering HIV prophylaxis to people who have been sexually assaulted: 16 months' experience in a sexual assault service. CMAJ 2000; 162:641-651.
19. Heppenstall-Heger A, McConnell G, Ticson L, Guerra L, Lister J, Zaragoza T. Healing patterns in anogenital injuries: A longitudinal study of injuries associated with sexual abuse, accidental injuries or genital surgery in the preadolescent child. Pediatrics 2003; 112:829-837.
20. Adams JA. Evolution of a classification scale: Medical evaluation of suspected child sexual abuse. Child Maltreatment 2001; 6:31-36.
21. Guidelines for the evaluation of sexual abuse of children: Committee on Child Abuse and Neglect. American Academy of Pediatrics. Pediatrics 1999; 103:186-191.